0001567619-20-006907.txt : 20200323
0001567619-20-006907.hdr.sgml : 20200323
20200323172907
ACCESSION NUMBER: 0001567619-20-006907
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200319
FILED AS OF DATE: 20200323
DATE AS OF CHANGE: 20200323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrison Scott W
CENTRAL INDEX KEY: 0001662426
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 20735843
MAIL ADDRESS:
STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC.
STREET 2: 400 EAST JAMIE COURT SUITE 101
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc1.xml
FORM 4
X0306
4
2020-03-19
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001662426
Morrison Scott W
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
1
0
0
0
Stock Option (Right to Buy)
2.00
2020-03-19
4
A
0
15000
0.00
A
2030-03-19
Common Stock
15000
15000
D
100% of the shares subject to the option vest and become exercisable on the one-year anniversary of the grant date, subject to continued service as a director through such date.
/s/ Leiv Lea, as Attorney-in-Fact for Scott W. Morrison
2020-03-20